Related Experiment Videos
TG-21 versus TG-25: a comparison for electrons
D S Followill1, D S Davis, W F Hanson
1Department of Radiation Physics, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Medical Physics
|July 1, 1997
Summary
This study compares electron beam dosimetry protocols, finding discrepancies between TG-25 and TG-21 methods, particularly for low-energy electrons. These differences impact absorbed dose determination in radiation therapy calibration.
Area of Science:
- Medical Physics
- Radiation Oncology
- Dosimetry
Background:
- The American Association of Physicists in Medicine Task Group 21 (TG-21) protocol has guided dosimetry reviews since 1984.
- The subsequent Task Group 25 (TG-25) report supplements TG-21 for electron-beam dosimetry beyond dmax.
- Confusion exists regarding which protocol to use for absolute electron beam calibration.
Purpose of the Study:
- To compare dosimetry discrepancies between TG-21, a modified TG-21 (RPC version), and TG-25.
- To analyze these discrepancies based on electron energy, chamber type, and phantom material.
Main Methods:
- Calculated dose differences using TG-21, RPC-modified TG-21, and TG-25 protocols.
- Evaluated results for 6 and 20 MeV electron beams.
- Assessed variations across cylindrical and parallel plate chambers using water, polystyrene, and acrylic phantoms.
Main Results:
- Largest discrepancies were observed between TG-25 and TG-21 methods for low-energy electrons in water and polystyrene.
- The mean difference across all conditions was 0.8%, with a maximum of 3.3% in polystyrene.
- Key contributors to differences include effective point of measurement, energy determination, stopping power ratios, and correction factors.
Conclusions:
- Discrepancies exist between TG-25 and TG-21 dosimetry protocols, necessitating careful consideration for electron beam calibration.
- Protocol selection impacts absorbed dose determination, particularly for low-energy electrons and specific phantom materials.
- Clarification is needed to ensure consistent and accurate dosimetry in radiation therapy clinical trials.